Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Fatigue, Lymphadenopathy
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 22Oct2021 11:00 (Lot number: 320308D) at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "asthma" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "sulfonamide allergy" (unspecified if ongoing), notes: known allergies: sulfa. Concomitant medication(s) included: FLU taken for immunisation, administration date 12Oct2021. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL0140, Location of injection: Arm Right, Vaccine Administration Time: 11:00 AM, Route of Administration: Intramuscular), administration date: 08Jan2021, when the patient was 63 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3248, Location of injection: Arm Right, Vaccine Administration Time: 11:00 AM, Route of Administration: Intramuscular), administration date: 26Jan2021, when the patient was 63 years old, for Covid-19 Immunization, reaction(s): "I didn't feel well with nonspecific symptoms", "Got a very unusual headache". The following information was reported: DIARRHOEA (non-serious) with onset 23Oct2021, outcome "recovering", described as "explosive watery diarrhoea x 2"; MYALGIA (non-serious) with onset 23Oct2021, outcome "recovering", described as "muscle aches"; CHILLS (non-serious) with onset 23Oct2021, outcome "recovering", described as "chills"; NAUSEA (non-serious) with onset 23Oct2021, outcome "recovering", described as "nausea"; FATIGUE (non-serious) with onset 23Oct2021, outcome "recovering", described as "fatigue"; LYMPHADENOPATHY (non-serious) with onset 23Oct2021, outcome "recovering", described as "I have bilateral, right > left axillary lymphadenopathy"; DECREASED APPETITE (non-serious) with onset 23Oct2021, outcome "recovering", described as "loss of appetite". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of diarrhoea, myalgia, chills, nausea, fatigue, lymphadenopathy, decreased appetite. Additional information: Patient was not pregnant at the time of Vaccination. Patient received FLU vaccine in right arm (other vaccine in four weeks). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. In early Sep. patient was exposed to PCR proven COVID through someone who lived in their home. Patient subsequently developed a bad sinus infection but had a negative COVID test, nasal PCR. They went away for 4 days to an isolated place, so no more testing was done, but there was good chance they both had a mild case of breakthrough COVID. I did not feel well with nonspecific symptoms and got a very unusual headache for 2 days. Sinus infection was treated with 2 courses of antibiotics (As reported). Seriousness reported as no. Follow-up attempts are completed. No further information is expected.